ClinicalTrials.govpublic full text
Long Term Safety of Anifrolumab in Adult Subjects With Active Systemic Lupus Erythematosus
active systemic lupus erythematosus, lupus erythematosus, systemic autoimmune diseases, connective tissue diseases,immune system diseases, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 811318
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.